Dopamine Receptor d1 anticorps (AA 11-100) (Cy5)

N° du produit ABIN2173730

L’anticorps anti-Dopamine Receptor d1 Polyclonal Lapin est utilisé pour la détection de Dopamine Receptor d1 dans des échantillons de Humain. Il a été validé pour WB, FACS, IF (p) et IF (cc).

Aperçu rapide pour Dopamine Receptor d1 anticorps (AA 11-100) (Cy5) (ABIN2173730)

Antigène: Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp Dopamine Receptor d1 est conjugé à/à la Cy5

Application: Western Blotting (WB), Flow Cytometry (FACS), Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunofluorescence (Cultured Cells) (IF (cc))

Détail du produit anti-Dopamine Receptor d1 anticorps (Cy5)

Épitope: AA 11-100

Fonction: DRD1 Polyclonal Antibody, Cy5 Conjugated

Réactivité croisée: Humain, Rat

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human Dopamine Receptor D1

Isotype: IgG

Information d'application

Indications d'application: WB(1:300-5000), FCM(1:20-100), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur Dopamine Receptor d1

Antigène: Dopamine Receptor d1 (DRD1) (Dopamine Receptor D1 (DRD1))

Autre désignation: Dopamine Receptor D1

Sujet:

Synonyms: DADR, DRD1A, D(1A) dopamine receptor, Dopamine D1 receptor, DRD1

Background: Dopamine receptor whose activity is mediated by G proteins which activate adenylyl cyclase.

ID gène: 1812

UniProt: P21728

Pathways: cAMP Metabolic Process, Inositol Metabolic Process, Protein targeting to Nucleus, Feeding Behaviour, Smooth Muscle Cell Migration, Regulation of long-term Neuronal Synaptic Plasticity